Abstract
Analyzing data from a prospective study of fatigue and Quality Of Life (QOL) in medically inoperable early stage lung cancer patients (pts) treated with stereotactic body radiotherapy (SBRT) revealed unexpected symptoms from some pts at first follow-up, prompting a review on the study's ability to provide accurate assessment of the outcomes of interest.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
